Recursive partitioning analysis of prognostic factors for patients with four or more intracranial metastases treated with radiosurgery

被引:22
作者
Bhatnagar, A. K. [1 ]
Kondziolka, D. [1 ]
Lunsford, L. Dade [1 ]
Flickinger, John C. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Ctr Image Guided Neurosurg, Dept Radiat Oncol, Pittsburgh, PA 15260 USA
关键词
radiosurgery; brain metastases; RPA; multiple brain metastases;
D O I
10.1177/153303460700600301
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The purpose of this study was to devise a new recursive partitioning analysis (RIPA) of patients with four or more intracranial metastases treated with a single radiosurgery procedure to identify a class of patients with extended survival. 205 patients underwent Gamma Knife radiosurgery for four or more intracranial metastases (median = 5, range 4-18) during one session. The median total treatment volume was 6.8 cc (range 0.6-51.0 cc). Radiosurgery was used as sole management (17% of patients), or in combination with WB-RT (46%), or after failure of WB-RT (38%). The median marginal radiosurgery dose was 16 Gy (range 12-20 Gy). RPA assessed the effects of age, Karnofsky > 70, extracranial disease, visceral metastases, number of metastases, total treatment volume, history of breast and melanoma primaries on survival. The median overall survival after radiosurgery for all patients was 8 months. RPA identified a favorable subgroup of 78 patients (43% of the series) with a total treatment volume < 7 cc and < 7 brain metastases (Class 1), with a median survival of 13 months. This subgroup's survival was significantly better (p < 0.00005) than the remaining patients (Class 2) (n=111) with a median survival of 6 months. In conclusion, RPA of multiple brain metastasis patients identified 2 distinct cohorts of patients. Class 1 patients have a total treatment volume < 7 cc and < 7 metastases (4-6) with favorable survival after Radiosurgery and Class 2 patients have a total treatment volume >= 7 cc and/or >= 7 metastases and have a significantly poorer survival.
引用
收藏
页码:153 / 159
页数:7
相关论文
共 46 条
[1]
Temozolomide for treating brain metastases [J].
Abrey, LE ;
Christodoulou, C .
SEMINARS IN ONCOLOGY, 2001, 28 (04) :34-42
[2]
Breast cancer with synchronous metastases: Trends in survival during a 14-year period [J].
Andre, F ;
Slimane, K ;
Bachelot, T ;
Dunant, A ;
Namer, M ;
Barrelier, A ;
Kabbaj, O ;
Spano, JP ;
Marsiglia, H ;
Rouzier, R ;
Delaloge, S ;
Spielmann, M .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (16) :3302-3308
[3]
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial [J].
Andrews, DW ;
Scott, CB ;
Sperduto, PW ;
Flanders, AE ;
Gaspar, LE ;
Schell, MC ;
Werner-Wasik, M ;
Demas, W ;
Ryu, J ;
Bahary, JP ;
Souhami, L ;
Rotman, M ;
Mehta, MP ;
Curran, WJ .
LANCET, 2004, 363 (9422) :1665-1672
[4]
Stereotactic radiosurgery for four or more intracranial metastases [J].
Bhatnagar, AK ;
Flickinger, JC ;
Kondziolka, D ;
Lunsford, LD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 64 (03) :898-903
[5]
Burri SH, 2004, NEUROSURGERY, V54, P1033, DOI 10.1227/01.NEU.0000117126.32806.A5
[6]
Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases [J].
Chidel, MA ;
Suh, JH ;
Reddy, CA ;
Chao, ST ;
Lundbeck, MF ;
Barnett, GH .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 47 (04) :993-999
[7]
Prospective study of stereotactic radiosurgery without whole brain radiotherapy in patients with four or less brain metastases: incidence of intracranial progression and salvage radiotherapy [J].
Chitapanarux, I ;
Goss, B ;
Vongtama, R ;
Frighetto, L ;
De Salles, A ;
Selch, M ;
Duick, M ;
Solberg, T ;
Wallace, R ;
Cabatan-Awang, C ;
Ford, J .
JOURNAL OF NEURO-ONCOLOGY, 2003, 61 (02) :143-149
[8]
Chougule P. B., 2000, International Journal of Radiation Oncology Biology Physics, V48, P114, DOI 10.1016/S0360-3016(00)80024-3
[9]
REGRESSION AND RECURSIVE PARTITION STRATEGIES IN THE ANALYSIS OF MEDICAL SURVIVAL-DATA [J].
CIAMPI, A ;
LAWLESS, JF ;
MCKINNEY, SM ;
SINGHAL, K .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1988, 41 (08) :737-748
[10]
Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer [J].
Clayton, AJ ;
Danson, S ;
Jolly, S ;
Ryder, WDJ ;
Burt, PA ;
Stewart, AL ;
Wilkinson, PM ;
Welch, RS ;
Magee, B ;
Wilson, G ;
Howell, A ;
Wardley, AM .
BRITISH JOURNAL OF CANCER, 2004, 91 (04) :639-643